Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Impax Fails to Win Approval for Parkinson’s Drug
Bloomberg
Monday, January 21, 2013 - 10:56am
tags:
Parkinson's Disease, Impax Labs, Rytary
2 Speculative Cancer Plays
Seeking Alpha
Monday, January 21, 2013 - 10:52am
tags:
Endocyte, Geron
Johnson & Johnson At Multi-Year Highs Ahead Of 4Q Earnings
Seeking Alpha
Monday, January 21, 2013 - 10:51am
tags:
earnings, JNJ
Biotie Considers Developing Alzheimer’s Drug on Its Own
Bloomberg
Monday, January 21, 2013 - 10:50am
tags:
BioTie Therapies, Alzheimer's disease, SYN120
4 Can't-Miss Health-Care Events This Week
Motley Fool
Monday, January 21, 2013 - 10:48am
tags:
Impax Labs, GSK, Rytary, Parkinson's Disease, JNJ, earnings, Intuitive Surgical
This Biotech's on the NuPathe to Success
Motley Fool
Monday, January 21, 2013 - 10:39am
tags:
NuPathe, GSK, migraines, Zecuity
Forbes Earnings Preview: Amgen
Forbes
Monday, January 21, 2013 - 10:38am
tags:
Amgen, earnings
Novartis gets EMA nod for Jetrea
FiercePharma
Saturday, January 19, 2013 - 12:14pm
tags:
Novartis, EMA, Jetrea, regulatory
Better Cancer Treatment: Partnerships and Dividends
The Motley Fool
Saturday, January 19, 2013 - 12:12pm
tags:
cancer, treatment, Isis Pharmaceuticals, Aegerion, Astra Zeneca
Synergy Pharmaceuticals Announces Closing of Merger With Callisto Pharmaceuticals
Yahoo/GlobeNewswire
Saturday, January 19, 2013 - 12:11pm
tags:
Synergy Pharmaceuticals, M&A, Callisto Pharmaceuticals
Forest Labs says Bystolic approved in Canada
Yahoo/AP
Saturday, January 19, 2013 - 12:10pm
tags:
Forest Labs, Bystolic, Canada
F.D.A. Clears Botox to Help Bladder Control
The New York Times
Saturday, January 19, 2013 - 12:10pm
tags:
FDA, Botox, bladder, regulatory
Faruqi & Faruqi, LLP Encourages Investors Who Suffered $100,000 In Losses Investing In Isis Pharmaceuticals, Inc. To Contact The Firm
Yahoo/PRNewswire
Saturday, January 19, 2013 - 12:09pm
tags:
investment, Isis Pharmaceuticals, legal
ThromboGenics Bid Seen on Eye Drug Treatment: Real M&A
Bloomberg
Saturday, January 19, 2013 - 12:07pm
tags:
ThromboGenics, eye, treatment
NuPathe Wins U.S. FDA Approval for Migraine Skin Patch
Bloomberg
Saturday, January 19, 2013 - 12:07pm
tags:
NuPathe, FDA, US, regulatory, migraine, migraine patch
Novartis Earnings: Patent Cliff Edition
The Motley Fool
Saturday, January 19, 2013 - 12:06pm
tags:
Novartis, patent, earnings
BGI-Shenzhen Extends Tender Offer For Complete Genomics, Inc.
Yahoo/PRNewswire
Saturday, January 19, 2013 - 12:06pm
tags:
BGI-Shenzhen, M&A, Complete Genomics
Arena Must Wait For European Approval
Seeking Alpha
Saturday, January 19, 2013 - 12:05pm
tags:
Arena Pharmaceutical, European, EU, regulatory, obesity, weight loss
The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Star Scientific, Inc. in Connection with Executive Compensation
Yahoo/BusinessWire
Saturday, January 19, 2013 - 11:15am
tags:
legal, investigation, Star Scientific
FDA Approval for Santarus' Uceris
Yahoo/Zacks
Saturday, January 19, 2013 - 11:14am
tags:
FDA, Santarus, Uceris, regulatory

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.